Baird Medical Investment Holdings (BDMD)
NASDAQ:BDMD
US Market
Holding BDMD?
Track your performance easily

Baird Medical Investment Holdings (BDMD) Income Statement

5 Followers

Baird Medical Investment Holdings Income Statement

Last quarter (Q ), Baird Medical Investment Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Baird Medical Investment Holdings's net income was $―. See Baird Medical Investment Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
-$ 31.46M$ 0.00$ 0.00
Cost of Revenue
-$ 4.23M--
Gross Profit
-$ 27.23M--
Operating Expense
$ 1.55M$ 15.38M$ 2.04M$ 706.66K
Operating Income
$ -1.55M$ 11.85M$ -2.04M$ -706.66K
Net Non Operating Interest Income Expense
$ 3.26M$ -284.27K$ 3.29M$ 9.69K
Other Income Expense
-$ -791.96K-$ 9.69K
Pretax Income
$ 1.71M$ 12.36M$ 1.24M$ -696.97K
Tax Provision
$ 620.35K$ 1.70M$ 620.35K-
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ 1.09M$ 10.55M$ 623.12K$ -696.97K
Basic EPS
$ 0.03$ 0.36$ 0.02$ -0.07
Diluted EPS
$ 0.03$ 0.36$ 0.02$ -0.07
Basic Average Shares
$ 86.25M$ 29.41M$ 28.75M$ 10.47M
Diluted Average Shares
$ 86.25M$ 29.41M$ 28.75M$ 10.47M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 1.55M$ 19.61M$ 2.04M$ 706.66K
Net Income From Continuing And Discontinued Operation
$ 1.09M$ 10.55M$ 623.12K$ -696.97K
Normalized Income
$ 1.09M$ 9.08M$ 623.12K$ -696.97K
Interest Expense
----
EBIT
$ -1.55M$ 12.65M$ -2.04M$ -706.66K
EBITDA
$ -1.55M$ 14.03M$ -2.04M$ -706.66K
Currency in USD

Baird Medical Investment Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis